SANGUEDOLCE, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 3.214
NA - Nord America 2.478
AS - Asia 746
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 10
OC - Oceania 9
AF - Africa 5
Totale 6.474
Nazione #
US - Stati Uniti d'America 2.471
IE - Irlanda 1.370
SE - Svezia 637
CN - Cina 583
UA - Ucraina 520
IT - Italia 294
FR - Francia 128
IN - India 90
FI - Finlandia 84
GB - Regno Unito 59
TR - Turchia 59
DE - Germania 50
ES - Italia 13
EU - Europa 10
GR - Grecia 10
AU - Australia 9
BE - Belgio 9
RU - Federazione Russa 9
NL - Olanda 6
AT - Austria 5
CA - Canada 5
CL - Cile 5
IR - Iran 5
PL - Polonia 5
BR - Brasile 4
CZ - Repubblica Ceca 3
JP - Giappone 3
RO - Romania 3
SG - Singapore 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
MG - Madagascar 2
MK - Macedonia 2
CH - Svizzera 1
DK - Danimarca 1
EG - Egitto 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 6.474
Città #
Dublin 1.370
Chandler 486
Nyköping 480
Jacksonville 357
Dearborn 222
New York 183
Nanjing 164
Princeton 141
Ashburn 94
Wilmington 90
Nanchang 78
Beijing 60
San Mateo 51
Shenyang 51
Helsinki 42
Ann Arbor 39
Foggia 27
Hebei 27
Tianjin 27
Rome 24
Kunming 23
Los Angeles 22
Pune 22
Bari 21
Jinan 21
Des Moines 18
Milan 18
Hangzhou 17
Jiaxing 17
Changsha 16
Boardman 12
Seattle 12
Reading 11
Guangzhou 10
Taizhou 10
Washington 10
Zhengzhou 10
Brussels 9
Ningbo 9
Norwalk 9
Borås 8
London 8
Redwood City 8
Woodbridge 8
Changchun 7
Marousi 7
Orange 7
Fuzhou 6
Chengdu 5
Chicago 5
Clearwater 5
Genoa 5
Hobart 5
Madrid 5
Pescara 5
Voghera 5
Hanover 4
Lavagna 4
Munich 4
Naples 4
Villasanta 4
Andria 3
Brno 3
Casalgrande 3
Florence 3
Houston 3
Isola del Liri 3
Leawood 3
Novokuznetsk 3
Paris 3
San Jose 3
San Severo 3
Santa Cruz de Tenerife 3
Shanghai 3
Singapore 3
Strasbourg 3
Tehran 3
Valencia 3
Ariccia 2
Asiago 2
Athens 2
Austin 2
Banja Luka 2
Bisceglie 2
Bitetto 2
Bitonto 2
Bologna 2
Budapest 2
Campinas 2
Castelli Calepio 2
Corleone 2
Coventry 2
Cupertino 2
Edinburgh 2
Galveston 2
Giovinazzo 2
Greensboro 2
Hefei 2
Kemerovo 2
Krakow 2
Totale 4.524
Nome #
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 131
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 130
A recurrent epidermoid cyst of the spleen: report of a case and literature review 112
Un caso di sarcoma di Kaposi viscerale in un paziente con morbo di crohn duodenale e immunodeficienza congenita. 106
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 98
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 97
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 92
Cyclooxygenase isozymes 1 and 2 in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations 88
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 87
Epigenetic inactivation of the WNT-pathway genes in oral squamous cell carcinoma. Preliminary report 85
Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy 84
Surgicel (R) granuloma mimicking ovarian cancer: A case report 84
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 83
Voluminous Omental Inflammatory Myofibroblastic Tumor in an Elderly Man: A Case Report and Literature Review 82
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 81
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 80
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 79
Epigenetic silencing of wnt-inhibitors: activation of a constitutive wnt signalling in oral cancer 79
Hemoperitoneum due to breaking uterine adenosarcoma located in the omentum. Report of a case 79
One stage surgery for synchronous liver metastasis from a neuroendocrine tumor of the colon. A case report 78
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 76
Asymptomatic solitary bladder plasmocytoma: A case report and literature review 75
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer 75
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 74
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 74
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 72
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 71
Pospho-protein-runx-2 expression is a prognostic marker of metastatic prostate carcinoma. 71
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 71
A lycopene and olives vegetation water compound improves lower urinary tract symptoms in men with histologically-proven benign prostatic hyperplasia and inflammation 71
Role of age in prostate and bladder cancer. A critical overview 71
A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study. 70
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 70
ARE WE DOING OUR BEST TO PREVENT THE (UNEXPECTED) DISAPPOINTING SIDE EFFECTS OF AN OTHERWISE SUCCESSFUL CANCER TREATMENT? 68
Magnetic resonance imaging of penile paraffinoma: Case report 68
Daily tadalafil for the chronic phase of stuttering priapism: A case report 67
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 67
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 66
Can inspection of the mouth help clinicians diagnose Crohn's disease? A review 66
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review 65
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 65
Detection of novel Human papilloma virus type 82 in laryngeal cancer: case report. 65
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 63
Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm 62
Molecular markers in bladder cancer: Novel research frontiers 62
p-NFkB expression in thyroid cancer. 61
Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. 60
An unusual delayed complication of paraffin self-injection for penile girth augmentation. 60
Asymptomatic bladder metastasis from breast cancer. 59
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy 59
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 57
Simultaneous radical nephroureterectomy and transurethral distal ureter balloon occlusion and detachment 57
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 57
Ectopic manifestation of a cholesterol granuloma in the nasopalatine duct 57
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 56
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 55
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 55
Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: A case report 55
Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets 55
Bladder metastasis from lung adenocarcinoma: a difficult differential diagnosis with primary bladder adenocarcinoma. 53
Multiple Skeletal Muscle Metastases from Colon Carcinoma Preceded by Paraneoplastic Dermatomyositis 52
Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use? 51
The complex relationship between upper urinary tract and bladder cancer: Clinical and predictive issues 51
Micropapillary bladder cancer, a variant histology of the elderly 51
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 50
Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions 50
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 50
Surgicel® granuloma mimicking ovarian cancer: A case report 48
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 48
Pilonidal cyst of the penis mimicking carcinoma. 47
Epidermoid cyst of the coronal sulcus mimicking penile cancer: a case report. 47
The broad landscape of follicular lymphoma: Part I 47
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 47
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 46
Elderly patients and prostate biopsy. How old is too old? 45
Prostate cancer biomarkers: a practical review based on different clinical scenarios 45
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 43
Osseous metaplasia within a urothelial bladder cancer nodal metastasis: a case report. 42
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 42
Increased expression of the autocrine motility factor is associated with poor prognosis in patients with clear cell-renal cell carcinoma 41
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 41
SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications 41
Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review 40
Modulation of complement activation by pentraxin-3 in prostate cancer 40
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 40
Urinary tract large cell neuroendocrine carcinoma: Diagnostic, prognostic and therapeutic issues 39
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 38
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 37
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 37
Molecular markers predicting disease outcome in bladder cancer. Should we shift from the classical cell-cycle regulators to her2 oncogene? 35
Prognostic and therapeutic role of HER2 expression in micropapillary carcinoma of the bladder 34
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  33
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 31
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere? 31
T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic Marker 29
Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study 29
Benign Lymphoepithelial Cyst of the Parotid Gland: Mind the Underlying Cause 29
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 25
Metastatic Cutaneous Basal Cell Carcinoma: Report of 2 Cases Preceding the Hedgehog Pathway Antagonists Era 25
PD-L1 as a prognostic and predictive biomarker in neuroendocrine tumors of the lung: state of the art and future perspectives 25
Totale 6.038
Categoria #
all - tutte 42.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019139 0 0 0 0 0 0 0 0 0 11 15 113
2019/20201.077 203 98 107 7 138 130 163 12 90 22 94 13
2020/2021611 90 5 74 12 81 12 89 33 97 98 11 9
2021/2022796 58 12 38 12 45 8 91 60 98 149 27 198
2022/20232.989 261 181 146 107 144 229 10 222 1.522 44 55 68
2023/2024628 83 37 36 20 38 273 72 38 10 21 0 0
Totale 6.969